Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P230040/S032

Cordella Pulmonary Artery Sensor System (CorPASS)

Endotronix, Inc. · Decision date Aug 13, 2026

FDA DECISIONP230040/S032

What did the FDA decide?

FDA records P230040/S032 as a supplement to PMA P230040, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Aug 13, 2026.

FDA approval order statement

introduce an alternate laser welding system
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Cardiovascular
Decision date
Aug 13, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P230040/S032
Regulatory pathway
PMA supplement
Product code
MOM
Decision code
OK30
Decision date
Aug 13, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: System, hemodynamic, implantable.

Product code
MOM
FDA device class
3

For the original device and its historical approval scope, see PMA P230040. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P230040 · Original PMA

    Cordella Pulmonary Artery Sensor System (CorPASS)

  2. P230040/S017 · Related supplement

    Cordella Pulmonary Artery Sensor System (CorPASS)

  3. P230040/S019 · Related supplement

    Cordella Pulmonary Artery Sensor System (CorPASS)

  4. P230040/S021 · Related supplement

    Cordella Pulmonary Artery Sensor System (CorPASS)

  5. P230040/S020 · Related supplement

    Cordella Pulmonary Artery Sensor System (CorPASS)

  6. P230040/S023 · Related supplement

    Cordella Pulmonary Artery Sensor System (CorPASS)

  7. P230040/S025 · Related supplement

    Cordella Pulmonary Artery Sensor System (CorPASS)

  8. P230040/S026 · Related supplement

    Cordella Pulmonary Artery Sensor System (CorPASS)

  9. P230040/S027 · Related supplement

    Cordella Pulmonary Artery Sensor System (CorPASS)

  10. P230040/S028 · Related supplement

    Cordella Pulmonary Artery Sensor System (CorPASS)

  11. P230040/S029 · Related supplement

    Cordella Pulmonary Artery Sensor System (CorPASS)

  12. P230040/S032 received

    Application receipt date recorded by FDA.

  13. P230040/S032 · FDA decision

    30-Day Notice

  14. P230040/S033 · Related supplement

    Cordella Pulmonary Artery Sensor System (CorPASS)

  15. P230040/S034 · Related supplement

    Cordella Pulmonary Artery Sensor System (CorPASS)

  16. P230040/S031 · Related supplement

    Cordelia Pulmonary Artery Pressure Sensor System (CorPASS)

  17. P230040/S035 · Related supplement

    Cordella Pulmonary Artery Sensor System (CorPASS)

  18. P230040/S030 · Related supplement

    Cordella Pulmonary Artery Sensor System

Timeline entries are records held by MedtechLedger for P230040. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P230040

Product / regulatory recordCompanyPathwayDecision dateSource
Endotronix, Inc.PMA approvalJun 20, 2024FDA
Endotronix, Inc.PMA supplementAug 14, 2025FDA
CorPASS SystemP230040/S018
Endotronix, Inc.PMA supplementAug 26, 2025FDA
Endotronix, Inc.PMA supplementSep 10, 2025FDA
Endotronix, Inc.PMA supplementSep 29, 2025FDA
Endotronix, Inc.PMA supplementSep 30, 2025FDA
CorPASS SystemP230040/S022
Endotronix, Inc.PMA supplementOct 6, 2025FDA
Endotronix, Inc.PMA supplementOct 22, 2025FDA
CorPASS SystemP230040/S024
Endotronix, Inc.PMA supplementNov 25, 2025FDA
CorPASS SystemP230040/S015
Endotronix, Inc.PMA supplementDec 19, 2025FDA
Endotronix, Inc.PMA supplementJan 9, 2026FDA
Endotronix, Inc.PMA supplementFeb 13, 2026FDA
Endotronix, Inc.PMA supplementFeb 17, 2026FDA
Endotronix, Inc.PMA supplementFeb 24, 2026FDA
Endotronix, Inc.PMA supplementMar 2, 2026FDA
Endotronix, Inc.PMA supplementSep 25, 2026FDA
Endotronix, Inc.PMA supplementOct 14, 2026FDA
Endotronix, Inc.PMA supplementOct 16, 2026FDA
Endotronix, Inc.PMA supplementOct 20, 2026FDA
Endotronix, Inc.PMA supplementOct 29, 2026FDA

Explore the linked device profile

Other records with product code MOM

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Endotronix, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
1415 W. Diehl Rd., Suite 500w, Naperville, IL, 60563

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records